Is thyroid cancer considered hyperthyroidism (an overactive thyroid) or hypothyroidism (an underactive thyroid)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Thyroid Cancer and Thyroid Function Status

Thyroid cancer itself is neither hyperthyroidism nor hypothyroidism, but most commonly presents as euthyroid (normal thyroid function). 1 However, thyroid function can be affected depending on the type, stage, and extent of the cancer.

Typical Thyroid Function in Thyroid Cancer

  • Most thyroid cancer patients have normal thyroid function at diagnosis
  • Thyroid function tests (TSH, Free T4) are typically within normal ranges
  • Thyroid cancer does not inherently cause dysfunction of hormone production in most cases

Exceptions: When Thyroid Cancer Can Affect Thyroid Function

Rare Cases of Hyperthyroidism in Thyroid Cancer

  • Hyperfunctioning thyroid cancer (causing hyperthyroidism) is rare but documented 2
  • Occurs primarily in:
    • Large metastatic follicular thyroid carcinomas with significant tumor burden
    • Cases where the large tumor mass produces excessive thyroid hormone despite poor efficiency
    • T3 toxicosis (elevated T3 with normal T4) is common in these cases

Hypothyroidism in Thyroid Cancer

  • Hypothyroidism is not typically caused by the cancer itself
  • Becomes common after treatment:
    • Following total thyroidectomy (surgical removal of the thyroid)
    • After radioactive iodine (RAI) therapy
    • These treatments necessitate lifelong thyroid hormone replacement 1

Thyroid Function Disorders in Cancer Patients

  • Cancer patients (even non-thyroid cancers) have higher rates of thyroid dysfunction (29.5%) compared to healthy individuals (15.4%) 3
  • Euthyroid sick syndrome is the most common thyroid abnormality in cancer patients (14%) 3
  • Both hyperthyroidism and hypothyroidism are more prevalent in cancer patients than in the general population

Anaplastic Thyroid Cancer Considerations

  • Anaplastic thyroid carcinoma (ATC) is an aggressive form with poor prognosis
  • Median survival from diagnosis is approximately 5 months 1
  • Thyroid function status is not typically affected by the cancer itself, but by treatment
  • Patients require levothyroxine if total thyroidectomy is performed 1

Clinical Implications

  • Thyroid function tests (TSH, Free T4) should be part of the initial workup for thyroid cancer
  • Imaging studies like ultrasound are used to evaluate thyroid morphology but do not help differentiate causes of thyroid dysfunction 1
  • After thyroidectomy for thyroid cancer, patients will require lifelong thyroid hormone replacement to prevent hypothyroidism
  • Higher thyroid hormone levels have been associated with advanced clinical stages of certain cancers 4, 5

Common Pitfalls

  • Failing to monitor thyroid function before, during, and after thyroid cancer treatment
  • Overlooking the possibility of hyperthyroidism in metastatic follicular carcinoma
  • Not recognizing that T3 toxicosis may occur with normal T4 levels in functioning thyroid cancer 2
  • Assuming all thyroid nodules found on imaging represent thyroid dysfunction (they often do not)

In summary, while thyroid cancer itself typically does not cause hyper- or hypothyroidism at presentation, thyroid function should be carefully monitored throughout the disease course and treatment, as dysfunction can develop due to treatment effects or, rarely, from the tumor itself.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Thyrotoxicosis caused by thyroid cancer.

Endocrinology and metabolism clinics of North America, 1990

Research

Higher thyroid hormone levels and cancer.

European journal of nuclear medicine and molecular imaging, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.